Literature DB >> 7649317

Impact of maternal HIV-1 infection on perinatal outcome.

R M Kumar1, S A Uduman, A K Khurranna.   

Abstract

OBJECTIVES: To study the impact of HIV-1 infection on pregnancy and maternal and early fetal outcome.
METHOD: From January 1992 to January 1993, 160 HIV-1 seropositive women and 164 HIV-1 seronegative age- and parity-matched pregnant tribal women from Manipur, India, were recruited into a prospective study. Mother and infant were followed until 6 weeks postpartum.
RESULTS: Nine percent (15/160) of subjects had AIDS (CDC IV), 38% (60/160) were symptomatic (CDC III) and 53% (85/160) were asymptomatic (CDC I/II). Symptomatic (CDC III/IV) HIV-1 infection is associated with a significantly increased rate of miscarriage, low birth weight, intrauterine fetal death and preterm delivery. Perinatal, infant and maternal deaths were limited to symptomatic women. HIV-1 infected women were significantly younger than their HIV-1 negative counterparts both in age and age at sexual debut. Placental membrane inflammation was significantly higher in the seropositive group and this correlated well with a higher risk of preterm delivery and postpartum endometritis. Asymptomatic HIV-1 infection was not associated with adverse pregnancy outcome.
CONCLUSION: Symptomatic (CDC III/IV) HIV-1 infection in Indian tribal women is associated with adverse maternal and fetal outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649317     DOI: 10.1016/0020-7292(95)02356-h

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  22 in total

1.  Expression of regulatory T cell (Treg) activation markers in endometrial tissues from early and late pregnancy in the feline immunodeficiency virus (FIV)-infected cat.

Authors:  N N Lockett; V L Scott; C E Boudreaux; B T Clay; S B Pruett; P L Ryan; K S Coats
Journal:  Placenta       Date:  2010-08-02       Impact factor: 3.481

2.  Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor.

Authors:  D A Dibbern; G W Glazner; I Gozes; D E Brenneman; J M Hill
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 3.  Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.

Authors:  Jennifer Prah Ruger; Christina M Lazar
Journal:  Addict Behav       Date:  2011-08-05       Impact factor: 3.913

4.  Brief Report: Markers of Spontaneous Preterm Delivery in Women Living With HIV: Relationship With Protease Inhibitors and Vitamin D.

Authors:  Adriana Weinberg; Yanling Huo; Deborah Kacanek; Kunjal Patel; D Heather Watts; Diane Wara; Risa M Hoffman; Jelena Klawitter; Uwe Christians
Journal:  J Acquir Immune Defic Syndr       Date:  2019-10-01       Impact factor: 3.731

5.  Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Authors:  Kunjal Patel; David E Shapiro; Susan B Brogly; Elizabeth G Livingston; Alice M Stek; Arlene D Bardeguez; Ruth E Tuomala
Journal:  J Infect Dis       Date:  2010-04-01       Impact factor: 5.226

6.  Expression of CD134 and CXCR4 mRNA in term placentas from FIV-infected and control cats.

Authors:  Veronica L Scott; Shane C Burgess; Leslie A Shack; Nikki N Lockett; Karen S Coats
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

Review 7.  Immunopathogenesis of feline immunodeficiency virus infection in the fetal and neonatal cat.

Authors:  Holly M Kolenda-Roberts; Leah A Kuhnt; Ryan N Jennings; Ayalew Mergia; Nazareth Gengozian; Calvin M Johnson
Journal:  Front Biosci       Date:  2007-05-01

Review 8.  Placental immunopathology in the FIV-infected cat: a role for inflammation in compromised pregnancy?

Authors:  Karen S Coats; Crystal E Boudreaux; Brittany T Clay; Nikki N Lockett; Veronica L Scott
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

9.  Maternal hematological and virological characteristics during early feline immunodeficiency virus (FIV) infection of cats as predictors of fetal infection and reproductive outcome at early gestation.

Authors:  Crystal E Boudreaux; Nikki N Lockett; Daniellé N Chemerys; Brittany T Clay; Veronica L Scott; Bridget Willeford; Timothy Brown; Karen S Coats
Journal:  Vet Immunol Immunopathol       Date:  2009-04-19       Impact factor: 2.046

10.  Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.

Authors:  Vlada V Melekhin; Bryan E Shepherd; Samuel E Stinnette; Peter F Rebeiro; Gema Barkanic; Stephen P Raffanti; Timothy R Sterling
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.